GCM
CELG

Gladius Capital Management’s Celgene Corp CELG Stock Holding History

Gladius Capital Management’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-16,500
Closed -$1.56M – 181
2019
Q1 		$1.56M Buy
16,500
+6,100
+59% +$533K 0.09% 95
2018
Q4 		$667K Buy
+10,400
New +$768K 0.03% 106

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $8.4B AUM 51.89% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $488M AUM 17.59% 1-Year Est. Return

Gladius Capital Management's CELG Position: Q4 2019 in Review

Gladius Capital Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 67 shares — an estimated $7K sold.

Gladius Capital Management first reported a position in CELG in Q4 2018 and held it in 4 quarters. The position peaked at $467K in Q4 2018. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Gladius Capital Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Gladius Capital Management sold 67 Celgene Corp shares in Q4 2019, an estimated $7K.
  • Gladius Capital Management first reported a position in Celgene Corp in Q4 2018 and held it in 4 quarters.
  • Gladius Capital Management's Celgene Corp position peaked at $467K in Q4 2018.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Gladius Capital Management's 13F filing for Q4 2019, filed 13 Feb 2020.